Literature DB >> 3481333

Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.

E W Rugendorff1.   

Abstract

The efficacies of ofloxacin and norfloxacin in the treatment of chronic complicated urinary tract infections were compared. 30 adult outpatients suffering from underlying urinary tract disease, with pyuria of 10 or more WBC/hpf and bacteriuria of 10(4) or more viable organisms per millilitre, were randomly assigned to receive ofloxacin 200mg once daily or norfloxacin 400mg twice daily for 10 days. After treatment pyuria was cleared in 9 cases and decreased or unchanged in 6 cases in the ofloxacin group. The corresponding numbers were 10 and 5 in the norfloxacin group. Bacteriuria was eliminated in 12 patients, unchanged in 1 and replaced in 2 in the ofloxacin group. In the norfloxacin group bacteriuria was eliminated in 8 cases, unchanged in 1, decreased in 1 and replaced in 5. The overall effectiveness rate was 14 of 15 in the ofloxacin group and 12 of 15 in the norfloxacin group. Ofloxacin 200mg once daily was as effective as norfloxacin 400mg twice daily in this open study.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3481333     DOI: 10.2165/00003495-198700341-00020

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  5 in total

Review 1.  Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.

Authors:  R Janknegt
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 4.  Quinolone antibacterial agents for the treatment of genitourinary tract infections.

Authors:  T J Babinchak; R J Fass
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 5.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.